Marex Group plc (MRX)
POSITIVEFundamental
63
Price
$70.88
Market Cap
-
Part 1 · What the company is worth
Overview
Marex Group Limited, a financial services platform company, provides liquidity, market access, and infrastructure services to clients in the commodity and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and fixed income, financial securities, digital assets, and equity futures and options; liquidity, execution, and risk management solutions to financial markets. It also provides liquidity to clients in the OTC energy markets; market data, analytics, and market commentary; energy services, including gas, power, environmental, and crude oil markets; and market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across a spectrum of markets, including agriculture, currency, and interest rate markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the digital assets business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, hedge funds, crypto-native trading firms, crypto exchange-traded product (ETP) providers, proprietary trading firms, independent asset managers, family offices, pension funds, index providers, and corporates; and a portfolio of structured Notes, OTC derivatives, crypto-settled instruments, CME crypto futures, cash and carry, and bitcoin and ethereum ETF. Additionally, the company offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. Marex Group Limited was incorporated in 2005 and is based in London, the United Kingdom.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance Sheet & Liquidity
Revenue
$759M
Trailing 12 months (through 9/30/2012)
Net Income
$80M
Trailing 12 months (through 9/30/2012)
Free Cash Flow
-
Total Equity
$832M
Total Liabilities
$620M
Current Ratio
2.73
Interest Coverage
5.77
Debt/EBITDA
-
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Historical statement
Margins over time
Debt over time
How heavy the debt is
Growth grid
Growth — Revenue
Fair Value Estimation
Fair Value
$76.97
Current Price
$70.88
Margin of Safety
+7.9%
Fair Value Range
$51.93 - $102.01
Estimation Methods
Valuation Metrics
P/E Ratio
53.85
ROE
15.2%
P/B Ratio
6.13
P/FCF
-
Gross Margin
89.5%
ROIC
4.2%
Profitability Radar
Value Creation (Economic Moat)
ROIC
4.2%
WACC
2.0%
ROIC − WACC
+2.1 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
Fundamental Analysis Criteria
Passed (11)
- Price CAGR 53.07%
- Gross Margin 89.5%
- Debt/Equity ratio
- Operating Margin 10.2%
- Current Ratio
- Interest Coverage
- Return on Tangible Assets
- ROE 28.4%
- Analyst Consensus 83% Buy
- Earnings Surprise avg 7.0%
- Earnings Quality (OCF/NI) 1.40
Failed (6)
- ROIC 4.2%
- P/B Ratio 6.13
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Unknown)
- Piotroski F-Score 3/9
Unavailable (10)
- EPS data insufficient
- P/FCF NaN
- Dividend Payout NaN%
- Positive Free Cash Flow
- CapEx intensity
- Debt/EBITDA
- Revenue Growth 5Y (Finnhub)
- PEG Ratio (need PE > 0 and growth > 0)
- Share Dilution (need 2+ years)
- Net Margin Trend (invalid data)
Piotroski F-Score
Serious financial concerns
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Buying back shares. Shareholder friendly
Governance
Executive Team
| Name | Title | Age |
|---|---|---|
| Mr. Ian Theo Lowitt | Group Chief Executive Officer | 61 |
| Mr. Crispin Robert John Irvin | Chief Financial Officer | 47 |
| Mr. Simon James Van Den Born | President | 58 |
| Mr. Michael Dugan | Chief Technology Officer | - |
| Mr. Adam Strachan | Head of Investor Relations | - |
| Mr. Nick Jones | Head of Legal | - |
| Ms. Ann Marie Bull | Group Head of Compliance | - |
| Ms. Anna Philbrick | Group Head of HR | - |
| Mr. Matthew France | Head of Institutional Sales, Metals for Asia | - |
| Mr. Harvey Moses | Head of Business Development | - |
Part 2 · The price and when to enter
This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.
Latest News
Recent headlines for MRX, sourced from Markets Gazette.
- 5/16/2026POSITIVEXRP ETF Accumulation Pushes Marex Group Among Top Holders
Marex Group Plc's stock surged over 15% in a single week, driven by the company's disclosure of a substantial $9.4 million investment in two spot XRP exchange-traded funds (ETFs). This strategic accumulation has positioned Marex among the leading institutional holders of XRP ETF shares within the United States. The significant market reaction suggests investor optimism regarding Marex's diversification into digital asset-related financial products and its potential to capitalize on the growing crypto ETF market. This move could signal a broader trend of traditional financial firms increasing their exposure to cryptocurrencies.
- 3/4/2026NEUTRALA Glimpse Into The Expert Outlook On Marex Group Through 5 Analysts
Recent analyst ratings for Marex Group Plc (MRX) present a mixed picture. In October 2012, Morgan Stanley maintained an 'Equal-Weight' rating, suggesting a neutral outlook on the stock. Earlier, in September 2012, Susquehanna downgraded the stock from 'Positive' to 'Neutral', indicating a potential weakening of prospects. While there are no very recent actions indicating strong positive or negative momentum, the presence of conflicting ratings suggests investors should closely monitor further developments and company communications before making investment decisions.
- 3/3/2026NEUTRALMarex Group (MRX) Q4 2025 Earnings Call Transcript
Marex Group (MRX) has announced the availability of the Q4 2025 earnings call transcript. However, the detailed content of this transcript is not yet publicly available. This is a routine event for publicly traded companies, typically preceding or following the release of full financial results. Investors and analysts eagerly await the analysis of key data points such as revenues, earnings per share, and future guidance, which could significantly impact the stock's valuation. The current lack of immediate information prevents a directional assessment, keeping the stock in a holding pattern pending the emerging details.
via Markets Gazette